Advertisement

Cancer management and reimbursement aspects in Germany: an overview demonstrated by the case of colorectal cancer

  • J.-Matthias von der SchulenburgEmail author
  • Anne Prenzler
  • Willemien Schurer
Original Paper

Abstract

This paper provides an overview of cancer management, particularly with respect to colorectal cancer (CRC), in Germany. The information presented reflects findings from the peer-review literature and government documentation, as well as interviews with cancer and CRC specialists. Topics such as epidemiology, expenditure, CRC screening, pharmaceutical and non-pharmaceutical treatment are discussed in this paper. Furthermore, insights into the German reimbursement system with regard to cancer management as well as regulatory aspects are presented.

Keywords

Colorectal cancer Cancer management Germany CRC Health policy 

JEL Classification

I11 I12 I18 

Notes

Conflict of interest statement

The authors do not report any conflict of interest associated with this paper.

References

  1. 1.
    Beske, F., Becker, E., Katalinic, A., Krauss, C., Pritzkuleit, R.: Health care 2050—Forecast for Germany and Schleswig-Holstein, Kiel (2007)Google Scholar
  2. 2.
    Robert Koch Institute (ed.): Cancer in Germany 2003–2004. Incidence and Trends. 6th edition, Berlin (2008)Google Scholar
  3. 3.
    Ferlay, J., Autie, P., Boniol, M., et al.: Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18, 581–592 (2007)CrossRefGoogle Scholar
  4. 4.
    Verdecchia, A., Francisci, S., Brenner, H., et al.: Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 data. Lancet Oncol. 8, 784–796 (2007)CrossRefGoogle Scholar
  5. 5.
    Berrino, F., De Angelis, R., Sant, M., et al.: Survival for eight major cancers and all cncers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol. 8, 773–783 (2007)CrossRefGoogle Scholar
  6. 6.
    Coleman, M.P., Gatta, G., Verdecchia, A., et al.: EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann. Oncol. 14, v128–v149 (2003)CrossRefGoogle Scholar
  7. 7.
    Staib, L., Link, K.H., Blatz, A., et al.: Surgery of colorectal cancer: surgical morbility and five- and ten-year results in 2400 patients—monoinstitutional experience. World J. Surg. 26, 59–66 (2002)CrossRefGoogle Scholar
  8. 8.
    Bray, F., Sankila, R., Ferlay, J., et al.: Estimates of cancer incidence and mortality in 1995. Eur. J. Cancer 38, 99–166 (2002)CrossRefGoogle Scholar
  9. 9.
    Federal Statistical Office: Costs of illness accounts. Wiesbaden (2008)Google Scholar
  10. 10.
    Sieg, A., Brenner, H.: Cost-saving analysis of screening colonoscopy in Germany. Z. Gastroenterol. 45, 945–951 (2007)CrossRefGoogle Scholar
  11. 11.
    Hieke, K., Kleeberg, U.R., Strauch, M., et al.: Costs of treatment of colorectal cancer in different settings in Germany. Eur. J. Health Econ. 5, 270–273 (2004)CrossRefGoogle Scholar
  12. 12.
    Damm, O., Hodek, J.-M., Greiner, W.: Methodological standards for cost-of-illness studies using breast cancer, prostate cancer and colon cancer as an example. ZEFQ 103, 305–316 (2009)Google Scholar
  13. 13.
    Robra, B.-P., Schwartz, F.W.: Experiences with a nationwide screening program for colorectal cancer in the Federal Republic of Germany. In: Hardcastle, J.D. (ed.) Haemoccult screening for the early detection of colorectal cancer. Schattauer, Stuttgart, New York (1986)Google Scholar
  14. 14.
    Altenhofen, L., Brenner, G., Pox, C., et al.: Feasibility and first results: national programme of screening colonoscopies in Germany 2003–2005. Central Research Institute of Ambulatory Health Care in Germany, Berlin (2007)Google Scholar
  15. 15.
    Altenhofen, L.: Results of the National Programme Screening Colonoscopies 2003–2008—a balance. Central Research Institute of Ambulatory Health Care in Germany, Berlin (2009)Google Scholar
  16. 16.
    Adler, A., Roll, S., Marowski, B., et al.: Appropriateness of colonoscopy in the era of colorectal cancer screening: a prospective, multicenter study in a private-practice setting (Berlin Colonoscopy Project 1, BECOP 1). Dis. Colon Rectum 50, 1628–1638 (2007)CrossRefGoogle Scholar
  17. 17.
    National Association of Statutory Health Insurance Physicians (ed.): Uniform Value Scale 2009. http://www.kbv.de/ebm2009/EBMGesamt.htm (2009) (Accessed 5 March 2009)
  18. 18.
    National Association of Statutory Health Insurance Physicians (ed.): Adjusted Valuation Committee according to § 87 paragraph 4 SGB V; meeting 27/28 August 27th/28th, 2008; agreement on monetary conversion factor for the year 2009 (2008)Google Scholar
  19. 19.
    Schmiegel, W., Pox, C., Aldler, G., et al.: Conference for medical guideline: Colorectal cancer. Z. Gastroenterol. 42, 1129–1177 (2004)CrossRefGoogle Scholar
  20. 20.
    Schmiegel, W., Pox, C., Reinacher-Schick, A., et al.: S3 medical guideline colorectal cancer. Results of the evidence-based consensus conference on February 6th/7th, 2004 and June 8th/9th, 2007 (for choosing the subject areas IV, VI and VII). Z. Gastroenterol. 46, 1–73 (2004)Google Scholar
  21. 21.
    Institute for the Hospital Remuneration System (ed.): Fee per case catalog 2008. Siegburg (2007)Google Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • J.-Matthias von der Schulenburg
    • 1
    Email author
  • Anne Prenzler
    • 1
  • Willemien Schurer
    • 2
  1. 1.Leibniz University HannoverHannoverGermany
  2. 2.LSE HealthLondon School of EconomicsLondonUK

Personalised recommendations